Insiders · VRPX

Eric Floyd

Director at Virpax Pharmaceuticals, Inc. (VRPX)

Eric Floyd has filed 5 insider reports with the SEC since April 2021, as director at Virpax Pharmaceuticals, Inc. (VRPX). Eric Floyd made no open-market purchases or sales in the last 12 months. The latest filing, on January 31, 2024, reports grant or award at Virpax Pharmaceuticals, Inc. (VRPX).

Filings
5
Companies
1
Bought on market
$6,107
Sold on market
None

Companies where Eric Floyd is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Virpax Pharmaceuticals, Inc. logo
VRPX
Virpax Pharmaceuticals, Inc.
Director8,018$6,107$1.36Jan 31, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Eric Floyd with

Other insiders at the same companies

Questions about Eric Floyd

What is Eric Floyd's role at Virpax Pharmaceuticals, Inc.?
Eric Floyd reports to the SEC as director at Virpax Pharmaceuticals, Inc. (VRPX), according to the latest filing on January 31, 2024.
How many shares does Eric Floyd own?
After the latest filing that states it, Eric Floyd directly owned 8,018 shares of Virpax Pharmaceuticals, Inc. (VRPX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Eric Floyd bought or sold stock recently?
The most recent open-market purchase was on May 18, 2022: bought 4,479 shares of Virpax Pharmaceuticals, Inc. (VRPX) for $6,107 at an average of $1.36.
How do I get alerts when Eric Floyd files?
Follow Eric Floyd on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Eric Floyd (SEC CIK 0001818469). Totals count each trade once, skipping amendments whose original is on file, from Apr 9, 2021 on. View on SEC EDGAR · Get this as JSON